The aim of this study is to investigate the effectiveness of pulsed Nd:YAG high-intensity laser therapy (HILT) on body weight (Wt), body–mass index (BMI), waist circumference (WC), forced vital capacity (FVC), and forced expiratory volume in 1 sec (FEV1) in young adults with abdominal obesity (AO).
Materials and methods:
Thirty-seven young adult males (age 19–25 years) with BMI >30 kg/m2 and WC >102 cm participated in this 12-week, randomized controlled study and were randomly allocated into either Group I [received pulsed Nd:YAG HILT plus moderate-intensity aerobic exercise training (AET) program] or Group II (received placebo pulsed Nd:YAG HILT plus the same AET program). The variables were evaluated pre- and poststudy.
Results:
Poststudy mean values and percentages of changes were calculated for Wt [83.7 ± 6.58 kg (−6.14%) and 88.71 ± 5.09 kg (−4.29%)], BMI [29.27 ± 1.06 kg/m2 (−6.14%) and 30.09 ± 1.23 kg/m2 (−4.24%)], WC [105.44 ± 5.84 cm (−3.78%) and 109.42 ± 4.9 cm (−1.74%)], FVC [4.79 ± 0.4 L (+13.6%) and 4.39 ± 0.66 L (+5.89%)], and FEV1 [4.04 ± 0.22 L (+16.4%) and 3.82 ± 0.39 L (+8.8%)] for Group I and Group II, respectively. Between groups, there were significant differences in mean values of Wt (p = 0.014), BMI (p = 0.04), WC (p = 0.03), FVC (p = 0.03), and FEV1 (p = 0.04) at the end of the study, but in favor of Group I.
Conclusions:
Utilizing the pulsed Nd:YAG HILT as an adjunctive therapeutic modality proved to be effective in improving the anthropometric indices and ventilatory functions in subjects with AO.
ChooiYC, DingC, MagkosF. The epidemiology of obesity. Metabolism, 2019; 92:6–10; doi: 10.1016/j.metabol.2018.09.005.
3.
LamBC, KohGC, ChenC, et al.Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS One, 2015; 10(4):e0122985; doi: 10.1371/journal.pone.0122985.
4.
BigaardJ, FrederiksenK, TjønnelandA, et al.Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes (Lond), 2005; 29(7):778–784; doi: 10.1038/sj.ijo.0802976.
5.
FismanEZ, TenenbaumA. Adiponectin: A manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?. Cardiovasc Diabetol, 2014; 13:103; doi: 10.1186/1475-2840-13-103.
WangY. Epidemiology of childhood obesity—Methodological aspects and guidelines: What is new?. Int J Obes Relat Metab Disord, 2004; 28Suppl 3:S21–S28; doi: 10.1038/sj.ijo.0802801.
8.
AlbertiKG, ZimmetP, ShawJ. Metabolic syndrome—A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med, 2006; 23(5):469–480; doi: 10.1111/j.1464-5491.2006.01858.x.
9.
BergmanRN, KimSP, CatalanoKJ, et al.Why visceral fat is bad: Mechanisms of the metabolic syndrome. Obesity (Silver Spring), 2006; 14Suppl 1:16S–19S; doi: 10.1038/oby.2006.277.
10.
TchernofA, DesprésJP. Pathophysiology of human visceral obesity: An update. Physiol Rev, 2013; 93(1):359–404; doi: 10.1152/physrev.00033.2011.
11.
DesprésJ-P, PoirierP, BergeronJ, et al.From individual risk factors and the metabolic syndrome to global cardiometabolic risk. Eur Heart J Suppl, 2008; 10(suppl_B):B24–B33; doi: 10.1093/eurheartj/sum041.
12.
CawleyJ, MeyerhoeferC. The medical care costs of obesity: An instrumental variables approach. J Health Econ, 2012; 31(1):219–230; doi: 10.1016/j.jhealeco.2011.10.003.
13.
World Health Organization. Global Status Report on Noncommunicable Diseases 2014. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/148114/ [Last accessed: September 20, 2022].
14.
PetersU, DixonAE. The effect of obesity on lung function. Expert Rev Respir Med, 2018; 12(9):755–767; doi: 10.1080/17476348.2018.1506331.
15.
LeoneN, CourbonD, ThomasF, et al.Lung function impairment and metabolic syndrome: The critical role of abdominal obesity. Am J Respir Crit Care Med, 2009; 179(6):509–516; doi: 10.1164/rccm.200807-1195OC.
16.
LittletonSW. Impact of obesity on respiratory function. Respirology, 2012; 17(1):43–49; doi: 10.1111/j.1440-1843.2011.02096.x.
17.
SteierJ, LuntA, HartN, et al.Observational study of the effect of obesity on lung volumes. Thorax, 2014; 69(8):752–759; doi: 10.1136/thoraxjnl-2014-205148.
18.
SaxenaY, SidhwaniG, UpmanyuR. Abdominal obesity and pulmonary functions in young Indian adults: A prospective study. Indian J Physiol Pharmacol, 2009; 53(4):318–326.
19.
RocheGC, ShanksS, JacksonRF, et al.Low-level laser therapy for reducing the hip, waist, and upper abdomen circumference of individuals with obesity. Photomed Laser Surg, 2017; 35(3):142–149; doi: 10.1089/pho.2016.4172.
20.
CroghanIT, HurtRT, SchroederDR, et al.Low-level laser therapy for weight reduction: A randomized pilot study. Lasers Med Sci, 2020; 35(3):663–675; doi: 10.1007/s10103-019-02867-5.
21.
VilianiT, PasquettiP. High intensity laser-therapy in hand osteoarthritis: A mixed protocol's proposal. Energy Health, 2012; 8:8–11.
22.
DundarU, TurkmenU, ToktasH, et al.Effectiveness of high-intensity laser therapy and splinting in lateral epicondylitis; A prospective, randomized, controlled study. Lasers Med Sci, 2015; 30(3):1097–1107; doi: 10.1007/s10103-015-1716-7.
23.
Starzec-ProserpioM, Grigol BardinM, FradetteJ, et al.High-intensity laser therapy (HILT) as an emerging treatment for vulvodynia and chronic musculoskeletal pain disorders: A systematic review of treatment efficacy. J Clin Med, 2022; 11(13):3701; doi: 10.3390/jcm11133701.
24.
BhammarDM, StickfordJL, BernhardtV, et al.Effect of weight loss on operational lung volumes and oxygen cost of breathing in obese women. Int J Obes (Lond), 2016; 40(6):998–1004; doi: 10.1038/ijo.2016.21.
25.
SekineA, WasamotoS, HagiwaraE, et al.Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity. Respir Invest, 2021; 59(2):247–251; doi: 10.1016/j.resinv.2020.10.002.
26.
BaltieriL, CazzoE, de SouzaAL, et al.Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up. Respir Med, 2018; 145:48–56; doi: 10.1016/j.rmed.2018.10.017.
AbdelaalAA, MohamadMA. Obesity indices and haemodynamic response to exercise in obese diabetic hypertensive patients: Randomized controlled trial. Obes Res Clin Pract, 2015; 9(5):475–486; doi: 10.1016/j.orcp.2014.11.001.
29.
WangS, SunX, HsiaTC, et al.The effects of body mass index on spirometry tests among adults in Xi'an, China. Medicine (Baltimore), 2017; 96(15):e6596; doi: 10.1097/MD.0000000000006596.
MafortTT, RufinoR, CostaCH, et al.Obesity: Systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med, 2016; 11:28–39; doi: 10.1186/s40248-016-0066-z.
32.
DonnellyJE, HonasJJ, SmithBK, et al.Aerobic exercise alone results in clinically significant weight loss for men and women: Midwest exercise trial 2. Obesity (Silver Spring), 2013; 21(3):E219–E228; doi: 10.1002/oby.20145.
33.
KrausWE, LevineBD. Exercise training for diabetes: The “strength” of the evidence. Ann Intern Med, 2007; 147(6):423–424; doi: 10.7326/0003-4819-147-6-200709180-00013.
34.
JensenMD, RyanDH, ApovianCM, et al.2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [published correction appears in Circulation 2014;129(25 Suppl 2):S139–S140]. Circulation, 2014; 129(25 Suppl 2):S102-S138; doi: 10.1161/01.cir.0000437739.71477.ee.
35.
FriedlanderAL, JacobsKA, FattorJA, et al.Contributions of working muscle to whole body lipid metabolism are altered by exercise intensity and training. Am J Physiol Endocrinol Metab, 2007; 292(1):E107–E116; doi: 10.1152/ajpendo.00148.2006.
36.
De FeoP. Is high-intensity exercise better than moderate-intensity exercise for weight loss?. Nutr Metab Cardiovasc Dis, 2013; 23(11):1037–1042; doi: 10.1016/j.numecd.2013.06.002.
37.
Al RashoudAS, AbboudRJ, WangW, et al.Efficacy of low-level laser therapy applied at acupuncture points in knee osteoarthritis: A randomised double-blind comparative trial. Physiotherapy, 2014; 100(3):242–248; doi: 10.1016/j.physio.2013.09.007.
38.
RomanoG, ContiA, FusiF. Laser-tissue interaction principles: Beam penetration in tissue (part II). Energy Health, 2010; 6:8–9.
39.
FortunaD, MasottiL. The HILT domain by the pulse intensity fluence (pif) formula. Energy Health, 2010; 5:12–19.
40.
VilianiT, MartiniC, MangoneG, et al.High Intensity Laser Therapy in knee osteoarthritis: Comparison between two different pulsed-laser treatment protocols. Energy Health, 2010; 5:26–29.
41.
AngelovaA, IlievaEM. Effectiveness of high intensity laser therapy for reduction of pain in knee osteoarthritis. Pain Res Manag, 2016; 2016:9163618; doi: 10.1155/2016/9163618.
42.
Pires OliveiraDA, de OliveiraRF, ZangaroRA, et al.Evaluation of low-level laser therapy of osteoblastic cells. Photomed Laser Surg, 2008; 26(4):401–404; doi: 10.1089/pho.2007.2101.
43.
MoniciM, CialdaiF, FusiF, et al.Effects of pulsed Nd: YAG laser at molecular and cellular level a study on the basis of Hilterapia. Energy Health, 2009; 3:26–33.
44.
JawadMM, Abdul QaderST, ZaidanAA, et al.An overview of laser principle, laser-tissue interaction mechanisms and laser safety precautions for medical laser users. Int J Pharmacol, 2011; 7(2):149–160; doi: 10.3923/ijp.2011.149.160.
45.
McRaeE, BorisJ. Independent evaluation of low-level laser therapy at 635 nm for non-invasive body contouring of the waist, hips, and thighs. Lasers Surg Med, 2013; 45(1):1–7; doi: 10.1002/lsm.22113.
46.
de AquinoAEJr, CarbinattoFM. The interaction between photonic technology and physical exercise: The action of low-level laser therapy. New Insights Obes Gene Beyond, 2017; 1:010–013; doi: 10.29328/journal.hodms.1001003.
47.
BarbosaP, CoimbraC, NoitesA, et al.Effect of one session of aerobic exercise associated with abdominal laser therapy in lipolytic activity, lipid profile, and inflammatory markers. J Cosmet Dermatol, 2021; 20(6):1714–1723; doi: 10.1111/jocd.13781.
48.
AquinoAE Jr, Sene-FioreseM, CastroCA, et al.Can low-level laser therapy when associated to exercise decrease adipocyte area?. J Photochem Photobiol B, 2015; 149:21–26; doi: 10.1016/j.jphotobiol.2015.04.033.
49.
DuarteFO, Sene-FioreseM, de Aquino JuniorAE, et al.Can low-level laser therapy (LLLT) associated with an aerobic plus resistance training change the cardiometabolic risk in obese women? A placebo-controlled clinical trial. J Photochem Photobiol B, 2015; 153:103–110; doi: 10.1016/j.jphotobiol.2015.08.026.
50.
da Silveira CamposRM, DâmasoAR, MasquioDCL, et al.The effects of exercise training associated with low-level laser therapy on biomarkers of adipose tissue transdifferentiation in obese women. Lasers Med Sci, 2018; 33(6):1245–1254; doi: 10.1007/s10103-018-2465-1.
51.
AvciP, NyameTT, GuptaGK, et al.Low-level laser therapy for fat layer reduction: A comprehensive review. Lasers Surg Med, 2013; 45(6):349–357; doi: 10.1002/lsm.22153.
52.
NeiraR, ArroyaveJ, RamirezH, et al.Fat liquefaction: Effect of low-level laser energy on adipose tissue. Plast Reconstr Surg, 2002; 110(3):912–925; doi: 10.1097/00006534-200209010-0003.
53.
KaruT. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B, 1999; 49(1):1–17; doi: 10.1016/S1011-1344(98)00219-X.
54.
JonesRL, NzekwuMM. The effects of body mass index on lung volumes. Chest, 2006; 130(3):827–833; doi: 10.1378/chest.130.3.827.
55.
BrazzaleDJ, PrettoJJ, SchachterLM. Optimizing respiratory function assessments to elucidate the impact of obesity on respiratory health. Respirology, 2015; 20(5):715–721; doi: 10.1111/resp.12563.
56.
HodgsonLE, MurphyPB, HartN. Respiratory management of the obese patient undergoing surgery. J Thorac Dis, 2015; 7(5):943–952; doi: 10.3978/j.issn.2072-1439.2015.03.08.
57.
BernhardtV, BabbTG. Weight loss reduces dyspnea on exertion in obese women. Respir Physiol Neurobiol, 2014; 204:86–92; doi: 10.1016/j.resp.2014.09.004.
